Invention Application
- Patent Title: LEWY BODY DISEASE THERAPEUTIC AGENT CONTAINING PYRAZOLOQUINOLINE DERIVATIVE
-
Application No.: US16611374Application Date: 2018-05-30
-
Publication No.: US20200155541A1Publication Date: 2020-05-21
- Inventor: Mai Miyamoto , Yukio Ishikawa
- Applicant: Eisai R&D Management Co., Ltd.
- Applicant Address: JP Bunkyo-ku, Tokyo
- Assignee: Eisai R&D Management Co., Ltd.
- Current Assignee: Eisai R&D Management Co., Ltd.
- Current Assignee Address: JP Bunkyo-ku, Tokyo
- International Application: PCT/JP2018/020650 WO 20180530
- Main IPC: A61K31/4745
- IPC: A61K31/4745 ; A61P25/28
Abstract:
Provided is a therapeutic agent for Lewy body disease comprising (S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quinolin-4(5H)-one represented by formula (I) or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US11311530B2 Lewy body disease therapeutic agent containing pyrazoloquinoline derivative Public/Granted day:2022-04-26
Information query
IPC分类:
